Phillip Minar

Cincinnati Children's Hospital Medical Center

Also affiliated with University of Cincinnati, University of Cincinnati Medical Center

Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 19 papers. Top paper: “Mucosal Inflammatory and Wound Healing Gene Programmes Reveal Targets for Stricturing Behaviour in Paediatric Crohn’s Disease”.

Mucosal Inflammatory and Wound Healing Gene Programmes Reveal Targets for Stricturing Behaviour in Paediatric Crohn’s Disease

Journal of Crohn s and Colitis(2020)10.1093/ecco-jcc/jjaa166

N/A

0.520DataRank · unranked

31 citations

Phillip Minar, Rebekah Karns, Phillip J. Dexheimer, Sudhir Ghandikota, Samuel Tegge +39 more

The Role of Therapeutic Drug Monitoring in Children

Gastroenterology Clinics of North America(2023)10.1016/j.gtc.2023.05.002

N/A

0.356DataRank · unranked

6 citations

Phillip Minar, Alexander Nasr

Use of Patient-Reported Outcomes Measurement Information System Pediatric Measures as Clinical Trial Endpoints: Experience from a Multicenter Pragmatic Trial in Children with Crohn’s Disease

The Journal of Pediatrics(2021)10.1016/j.jpeds.2021.10.053

N/A

0.330DataRank · unranked

8 citations

Julia Schuchard, Adam C. Carle, Christopher B. Forrest, Michael D. Kappelman, Jeremy Adler +35 more

Infliximab Monotherapy vs Combination Therapy for Pediatric Crohn’s Disease Exhibit Similar Pharmacokinetics

Inflammatory Bowel Diseases(2023)10.1093/ibd/izad307

N/A

0.292DataRank · unranked

6 citations

S Vuijk, Ron A. A. Mathôt, Johan Van Limbergen, M Jongsma, Marco W.J. Schreurs +4 more

Circulating and Magnetic Resonance Imaging Biomarkers of Intestinal Fibrosis in Small Bowel Crohn’s Disease

Inflammatory Bowel Diseases(2025)10.1093/ibd/izae319

N/A

0.104DataRank · unranked

1 citations

Jean A. Tkach, Joel G. Fletcher, David H. Bruining, Aiming Lu, Subra Kugathasan +20 more

Model-informed Precision Dosing for Biologics Is Now Available at the Bedside for Patients With Inflammatory Bowel Disease

Inflammatory Bowel Diseases(2022)10.1093/ibd/izac237

N/A

0DataRank · unranked

17 citations

Abigail Samuels, Tomoyuki Mizuno, Nieko Punt, Alexander A. Vinks, Phillip Minar +1 more

Targeted Assessment of Mucosal Immune Gene Expression Predicts Clinical Outcomes in Children with Ulcerative Colitis

Journal of Crohn s and Colitis(2022)10.1093/ecco-jcc/jjac075

N/A

0DataRank · unranked

6 citations

Rebekah Karns, Anil G. Jegga, Mihika Sharma, Sejal R. Fox, Babajide Ojo +19 more

Precision Dosing of Anti-TNF Therapy in Pediatric Inflammatory Bowel Disease

Current Gastroenterology Reports(2023)10.1007/s11894-023-00895-4

N/A

0DataRank · unranked

17 citations

Kaitlin G. Whaley, Phillip Minar, Abigail Samuels

Acute pancreatitis is associated with gut dysbiosis in children

Digestive and Liver Disease(2023)10.1016/j.dld.2023.10.011

N/A

0DataRank · unranked

7 citations

Nicholas J. Ollberding, Tyler Thompson, Nicole Kotha, Phillip Minar, David S. Vitale +6 more

Integrating early response biomarkers in pharmacokinetic models: A novel method to individualize the initial infliximab dose in patients with Crohn's disease

Clinical and Translational Science(2025)10.1111/cts.70086

N/A

0DataRank · unranked

6 citations

Kei Irie, Tomoyuki Mizuno, Jack Reifenberg, Nieko Punt, Alexander A. Vinks +2 more

Hybrid Population Pharmacokinetic–Machine Learning Modeling to Predict Infliximab Pharmacokinetics in Pediatric and Young Adult Patients with Crohn’s Disease

Clinical Pharmacokinetics(2025)10.1007/s40262-025-01564-7

N/A

0DataRank · unranked

6 citations

Phillip Minar, Jack Reifenberg, Brendan M. Boyle, Joshua D. Noe, Jeffrey S. Hyams +2 more

Model‐Informed Deep Q‐Networks to Guide Infliximab Dosing in Pediatric Crohn’s Disease

Clinical Pharmacology & Therapeutics(2025)10.1002/cpt.70118

N/A

0DataRank · unranked

2 citations

Phillip Minar, Jack Reifenberg, Brendan M. Boyle, Joshua D. Noe, Jeffrey S. Hyams +2 more

Hybrid Population PK-Machine Learning Modeling to Predict Infliximab Pharmacokinetics in Pediatric and Young Adult Patients with Crohn’s Disease

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.05.01.651780

N/A

0DataRank · unranked

0 citations

Phillip Minar, Jack Reifenberg, Brendan M. Boyle, Joshua D. Noe, Jeffrey S. Hyams +2 more

Real‐World Infliximab Pharmacokinetic Study Informs an Electronic Health Record‐Embedded Dashboard to Guide Precision Dosing in Children with Crohn’s Disease

Clinical Pharmacology & Therapeutics(2020)10.1002/cpt.2148

N/A

0DataRank · unranked

72 citations

Tomoyuki Mizuno, Ruben J. Colman, Jeffrey S. Hyams, Joshua D. Noe, Brendan Boyle +9 more

Model-informed Deep Q-Networks to Guide Infliximab Dosing in Pediatric Crohn’s Disease

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.07.14.664804

N/A

0DataRank · unranked

0 citations

Phillip Minar, Jack Reifenberg, Brendan M. Boyle, Joshua D. Noe, S Jeffrey Hyams +2 more

Effect of a Practice-wide Anti-TNF Proactive Therapeutic Drug Monitoring Program on Outcomes in Pediatric Patients with Inflammatory Bowel Disease

Inflammatory Bowel Diseases(2020)10.1093/ibd/izaa102

N/A

0DataRank · unranked

53 citations

Aditi Mulgund, Laura E. Bauman, Weizhe Su, Lin Fei, Deepika L. Chona +8 more

Achieving Target Infliximab Drug Concentrations Improves Blood and Fecal Neutrophil Biomarkers in Crohn’s Disease

Inflammatory Bowel Diseases(2020)10.1093/ibd/izaa241

N/A

0DataRank · unranked

22 citations

Yi‐Ting Tsai, Kimberly Jackson, Brendan M. Boyle, Joshua D. Noe, Jeffrey S. Hyams +6 more

Favorable Outcomes and Anti-TNF Durability After Addition of an Immunomodulator for Anti-Drug Antibodies in Pediatric IBD Patients

Inflammatory Bowel Diseases(2020)10.1093/ibd/izaa108

N/A

0DataRank · unranked

30 citations

Andrea Portocarrero-Castillo, Deepika L. Chona, Jennifer Hellmann, Phillip Minar, Michael J. Rosen +1 more

Real world population pharmacokinetic study in children and young adults with inflammatory bowel disease discovers novel blood and stool microbial predictors of vedolizumab clearance

Alimentary Pharmacology & Therapeutics(2022)10.1111/apt.17277

N/A

0DataRank · unranked

24 citations

Tomoyuki Mizuno, Keizo Fukushima, David Haslam, Jeffrey S. Hyams, Brendan Boyle +10 more